Screener
Alnylam Pharmaceuticals ALNY Total debt
Total debt at other companies
Other financials
Where this comes from
Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $256.43M.
The source filing: Alnylam Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 8:11 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001178670-26-000062
FAQ
- What is Alnylam Pharmaceuticals's total debt?
- Alnylam Pharmaceuticals (ALNY) reported total debt of $256.43M in Q2 2026.
- How has Alnylam Pharmaceuticals's total debt changed year-over-year?
- Alnylam Pharmaceuticals's total debt decreased by 5.2% year-over-year, from $270.54M to $256.43M.
- What is the long-term trend for Alnylam Pharmaceuticals's total debt?
- Over 5 years (2020 to 2025), Alnylam Pharmaceuticals's total debt has grown at a -12.3% compound annual growth rate (CAGR), from $521.19M to $270.61M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.
Ask your AI about Alnylam Pharmaceuticals's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude